Acquisition of myogenic specificity by replacement of three amino acid residues from MyoD into E12.
about
Muscle LIM protein promotes myogenesis by enhancing the activity of MyoDNeuroD2 and neuroD3: distinct expression patterns and transcriptional activation potentials within the neuroD gene familyMultiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2Activated notch inhibits myogenic activity of the MADS-Box transcription factor myocyte enhancer factor 2CCombinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factorsNeuroD1/beta2 contributes to cell-specific transcription of the proopiomelanocortin geneThe basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, TwistMolecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2CCasein kinase II increases the transcriptional activities of MRF4 and MyoD independently of their direct phosphorylationReprogramming cells with synthetic proteinsDifferential modulation of cell cycle progression distinguishes members of the myogenic regulatory factor family of transcription factorsMyoD uses overlapping but distinct elements to bind E-box and tetraplex structures of regulatory sequences of muscle-specific genesCharacterization of the transcription activation function and the DNA binding domain of transcriptional enhancer factor-1TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3Activation and function of murine Cyclin T2A and Cyclin T2B during skeletal muscle differentiationMyoR: a muscle-restricted basic helix-loop-helix transcription factor that antagonizes the actions of MyoDDecoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1A novel basic helix-loop-helix protein is expressed in muscle attachment sites of the Drosophila epidermis.Intramolecular regulation of MyoD activation domain conformation and functionAnalysis of homeodomain function by structure-based design of a transcription factor.Transcription factor BETA2 acts cooperatively with E2A and PDX1 to activate the insulin gene promoter.Genetic and molecular analysis of the autosomal component of the primary sex determination signal of Drosophila melanogaster.Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo.The basic domain of ATH5 mediates neuron-specific promoter activity during retina development.The Mad and Myc basic domains are functionally equivalent.Neuronal type information encoded in the basic-helix-loop-helix domain of proneural genes.Positive control mutations in the MyoD basic region fail to show cooperative DNA binding and transcriptional activation in vitro.Alteration of a single serine in the basic domain of the Epstein-Barr virus ZEBRA protein separates its functions of transcriptional activation and disruption of latency.The high mobility group protein HMG I(Y) can stimulate or inhibit DNA binding of distinct transcription factor ATF-2 isoforms.In vivo interactions of the Drosophila Hairy and Runt transcriptional repressors with target promoters.MyoD induces myogenic differentiation through cooperation of its NH2- and COOH-terminal regions.The E2A gene product contains two separable and functionally distinct transcription activation domains.Ras p21Val inhibits myogenesis without altering the DNA binding or transcriptional activities of the myogenic basic helix-loop-helix factors.Tumor cell complementation groups based on myogenic potential: evidence for inactivation of loci required for basic helix-loop-helix protein activityCyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation.A novel myogenic regulatory circuit controls slow/cardiac troponin C gene transcription in skeletal muscle.A heterodimer of HEB and an E12-related protein interacts with the CD4 enhancer and regulates its activity in T-cell linesFunctional studies of the Ciona intestinalis myogenic regulatory factor reveal conserved features of chordate myogenesisIn vitro transcription system delineates the distinct roles of the coactivators pCAF and p300 during MyoD/E47-dependent transactivation.The E12 inhibitory domain prevents homodimer formation and facilitates selective heterodimerization with the MyoD family of gene regulatory factors.
P2860
Q24319090-43381A5E-70AF-4D75-8660-EBD8617F181BQ24336695-0EF65F60-31D6-4504-820B-FBA6C92146DAQ24533544-95C2C61E-DB25-46EC-9AEA-638F2EFF7572Q24554516-F4BF3C3D-65E7-43F3-932E-FA56D77DA098Q24594377-68E44A73-80F2-4504-98DC-FF61E3A04073Q24644235-52508B85-B010-4B15-82A1-5EFA88CC0AD8Q24644315-054C2BE6-2527-42AD-9A5E-DE20A3DB9AA6Q24647260-DB279052-F826-4CB8-AD1B-0C7ABF50B77BQ24650282-5DD66D65-28F4-4192-8C9C-176192286623Q26853155-DE970C0E-C525-4728-985F-8DCE3B137027Q27022808-35EEEB69-5898-441A-A872-85A5401BAD26Q28253648-64F9E1B1-A46D-4A09-95FC-626F3D37D791Q28263487-652BC0B7-D1CB-479A-BBA8-285F327C973DQ28364253-0F1F8EC7-7F17-4B18-ACB6-1701754008B8Q28511857-85BAE5F1-E7E1-4EE2-96BF-C907F59DC81FQ28592398-413B02C0-3AD2-4893-AD2B-7791150EE318Q28594728-D266BF5C-C371-4227-B197-5CCD0B3C4597Q30450213-848EAED1-E3C9-47A4-B6E0-381DBD8A9D7AQ33778990-52C97DFF-2D02-401E-960A-94C630E66481Q33868562-6875EDE9-3C67-46AD-A96F-596E0A996CA2Q33886670-F66FD73F-56B7-4324-83C5-F1C40ECDDBBAQ33966305-203707D4-21E2-4B63-BFDB-C1B37132910EQ34074572-2377D1D9-7E84-4D5D-902E-46DA06FB79A3Q34124175-23CAA348-A942-4D26-B768-DC23889EBBA4Q34171815-FFC4D6B3-A51E-430D-A9D5-42798606BB9FQ34407350-2E40881F-E3CB-46C0-A67B-8B32015B2BCAQ35561501-294FEF85-4150-4FBA-BB40-6D65E2AA24DFQ35881137-4E7C449B-4189-4C96-A507-65DA994B5D87Q35908477-302D9064-C9C3-4104-A307-3E06842CECC0Q35917558-9A0E7577-7FBF-4F92-909F-5D761CF22CAFQ36320492-3F24CBA7-4975-4A2E-B3C1-BB3E83C1595AQ36507951-E635CBDB-4D02-4217-9FE8-2C5D46660908Q36554923-52D836DF-3E49-4F46-89BE-921784FC1E24Q36561028-6449C823-A1D7-4301-A4DF-0FB2E166E226Q36564360-59EBBDC3-0790-4A6A-862E-417A30887E65Q36647972-3B51ED74-8F38-486D-9933-3E1B2936CBBEQ36700487-80F5DB6D-8585-4E6D-8269-EDD384E5D808Q36904587-464BB8AD-87D9-4B14-A659-352529426609Q37415625-8FDAE860-E551-4474-B2C6-D401857A0687Q37696378-C952B262-632E-46B3-9672-4944F7D2E067
P2860
Acquisition of myogenic specificity by replacement of three amino acid residues from MyoD into E12.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Acquisition of myogenic specif ...... d residues from MyoD into E12.
@en
type
label
Acquisition of myogenic specif ...... d residues from MyoD into E12.
@en
prefLabel
Acquisition of myogenic specif ...... d residues from MyoD into E12.
@en
P356
P1433
P1476
Acquisition of myogenic specif ...... d residues from MyoD into E12.
@en
P2093
P304
P356
10.1126/SCIENCE.1317057
P407
P577
1992-05-01T00:00:00Z